Loading…
This event has ended. Create your own event on Sched.
Back To Schedule
Friday, March 15 • 7:00am - 5:00pm
PO090: Preclinical Evaluation Of NCX 4251, A Novel Steroid Therapy For Blepharitis, Targeted Directly To The Eyelid Margin To Reduce The Potential For IOP Elevations

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Tweet Share
View Abstract
Speakers
RD

Friday March 15, 2019 7:00am - 5:00pm PDT
Atrium – Second Floor San Francisco Marriott Marquis
  Posters